These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4575063)

  • 21. [Anemia in chronic renal insufficiency].
    Heilmann E
    Fortschr Med; 1975 Dec; 93(34):1718-20. PubMed ID: 1193526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anemia in terminal kidney failure. Pathogenesis and therapy].
    Heilmann E
    Fortschr Med; 1977 Feb; 95(6):338-44. PubMed ID: 838456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA
    Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The correction of anemia with a high requirement for transfusion in patients on maintenance hemodialysis by conventional and reduced doses of recombinant human erythropoietin].
    Sivak L; Scuteri RM; Cavalli NH; Gotlieb D; López Blanco OA
    Medicina (B Aires); 1992; 52(6):516-22. PubMed ID: 1340900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Testosterone treatment of renal anemia. Evaluation of success by means of morphometric bone marrow and erythrocyte volume determinations].
    Keyssner J; Hauswaldt C; Uhl N; Hunstein W
    Schweiz Med Wochenschr; 1974 Dec; 104(52):1938-41. PubMed ID: 4432057
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of anemia associated with chronic renal failure. I. Effects of the large dose of androgen on long term hemodialyzed patients].
    Ono Y; Moriyama Y; Nishino I; Saito H; Kinoshita Y
    Rinsho Ketsueki; 1973 Jan; 14(1):58-66. PubMed ID: 4734791
    [No Abstract]   [Full Text] [Related]  

  • 27. Iron overload in the erythropoietin era.
    Robbins KC
    Nephrol Nurs J; 2000 Apr; 27(2):227-31. PubMed ID: 11111550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disorders of red blood cell production in uremia.
    Eschbach JW; Adamson JW; Cook JD
    Arch Intern Med; 1970 Nov; 126(5):812-5. PubMed ID: 5475703
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin.
    Chandra M; McVicar M; Clemons GK
    Adv Pediatr; 1988; 35():361-89. PubMed ID: 3055863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment experience with anemia in chronic kidney failure patients].
    Shostka GD
    Klin Med (Mosk); 1984 Jun; 62(6):60-6. PubMed ID: 6471800
    [No Abstract]   [Full Text] [Related]  

  • 34. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of iron in patients on chronic dialysis: mistake and misconceptions.
    Sakiewicz P; Paganini E
    J Nephrol; 1998; 11(1):5-15. PubMed ID: 9561479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenectomy for anaemia in patients on regular haemodialysis.
    Hartley LC; Morgan TO; Innis MD; Clunie GJ
    Lancet; 1971 Dec; 2(7738):1343-5. PubMed ID: 4108263
    [No Abstract]   [Full Text] [Related]  

  • 37. [Etiopathogenic mechanisms of anemia in hemodialysis patients].
    Marco Franco JE; Alarcón Zurita A; Dalmau Diana M; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Ribas Mundó M
    Rev Clin Esp; 1983 Jan; 168(2):83-5. PubMed ID: 6344155
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recombinant human erythropoietin].
    Frenken LA; Koene RA
    Ned Tijdschr Geneeskd; 1988 Mar; 132(10):432-4. PubMed ID: 3347279
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of renal anemia with recombinant human erythropoietin].
    Burghard R; Gordjani N; Leititis JU
    Monatsschr Kinderheilkd; 1989 Mar; 137(3):174-7. PubMed ID: 2716749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.